Page last updated: 2024-10-21

vanillin and Venous Thromboembolism

vanillin has been researched along with Venous Thromboembolism in 1 studies

Vanilla: A plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines (FLAVORING AGENTS).

Venous Thromboembolism: Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dua, T3
Mangal, S3
Akshita, G3
Atri, AK3
Sharma, P3
Harjai, K3
Singh, V3

Other Studies

1 other study available for vanillin and Venous Thromboembolism

ArticleYear
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023
Novel Vanillin-based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
    Drug development research, 2023, Volume: 84, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Humans; Molecular Docking Simulation; Phytochemicals; Pseudomonas a

2023